Cite
HARVARD Citation
Wang, T. et al. (2021). Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidation. Leukemia & lymphoma. 62 (4), pp. 995-998. [Online].